Drug Search Results
More Filters [+]

CH-505W53

Alternative Names: ch-505w53, ch505w53, ch 505w53
Latest Update: 2023-06-22
Latest Update Note: Clinical Trial Update

Product Description

HIV vaccine (Sourced from: https://clinicaltrials.gov/ct2/show/NCT03220724)

Mechanisms of Action: Vaccine

Novel Mechanism: No

Modality: Vaccine

Route of Administration: Intramuscular

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: National Institute of Allergy and Infectious Diseases (NIAID)
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for CH-505W53

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title